Cargando…

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer

Gallbladder cancer (GBC) is a lethal cancer with poor prognosis associated with high invasiveness and poor response to chemotherapy and radiotherapy. New therapeutic approaches are urgently needed in order to improve survival and response rates of GBC patients. We screened 130 small molecule inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Helga, Valbuena, José R., Barbhuiya, Mustafa A., Stein, Stefan, Kunkel, Hana, García, Patricia, Bizama, Carolina, Riquelme, Ismael, Espinoza, Jaime A., Kurtz, Stephen E., Tyner, Jeffrey W., Calderon, Juan Francisco, Corvalán, Alejandro H., Grez, Manuel, Pandey, Akhilesh, Leal-Rojas, Pamela, Roa, Juan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432248/ https://www.ncbi.nlm.nih.gov/pubmed/28412732 http://dx.doi.org/10.18632/oncotarget.15410

Ejemplares similares

Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
por: Weber, Helga, et al.
Publicado: (2015)

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
por: Riquelme, Ismael, et al.
Publicado: (2015)

HSP90 inhibitor 17AAG attenuates sevoflurane-induced neurotoxicity in rats and human neuroglioma cells via induction of HSP70
por: Liu, Min, et al.
Publicado: (2020)

Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer
por: Zajac, Magdalena, et al.
Publicado: (2010)

The Hsp90 inhibitor 17-AAG represses calcium-induced cytokeratin 1 and 10 expression in HaCaT keratinocytes
por: Miyoshi, Sadanori, et al.
Publicado: (2012)

Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
por: Powers, Marissa V, et al.
Publicado: (2013)

Topically applied Hsp90 inhibitor 17AAG inhibits ultraviolet radiation-induced cutaneous squamous cell carcinomas
por: Singh, Anupama, et al.
Publicado: (2014)

HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages
por: Zhang, Shuo, et al.
Publicado: (2022)

Role of lncRNAs in the Development of an Aggressive Phenotype in Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2021)

Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2022)

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
por: Kasai, Shuya, et al.
Publicado: (2016)

The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells
por: Hirakawa, Hirokazu, et al.
Publicado: (2015)

The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells
por: Schaefer, Susanne, et al.
Publicado: (2017)

Corrigendum: Bioinformatics Analysis Identififies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs
por: Peng, Ying, et al.
Publicado: (2022)

The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice
por: Hong, Liang-Jian, et al.
Publicado: (2020)

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
por: Shu, Xiong, et al.
Publicado: (2023)

A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
por: Vergara-Gómez, Luis, et al.
Publicado: (2023)

PARP inhibitors protect against sex- and AAG-dependent alkylation-induced neural degeneration
por: Allocca, Mariacarmela, et al.
Publicado: (2017)

MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
por: Sandoval-Bórquez, Alejandra, et al.
Publicado: (2017)

Correction to: MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
por: Sandoval-Bórquez, Alejandra, et al.
Publicado: (2021)

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer
por: García, Patricia, et al.
Publicado: (2020)

Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
por: Vishal, Chaturvedi, et al.
Publicado: (2011)

Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?()
por: Mehta, Adi, et al.
Publicado: (2013)

Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
por: Patwardhan, Chaitanya A., et al.
Publicado: (2023)

A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
por: Hanna, Reine, et al.
Publicado: (2021)

Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages
por: Petersen, Antonio Luis de Oliveira Almeida, et al.
Publicado: (2018)

Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG
por: Lee-Theilen, Mieun, et al.
Publicado: (2021)

Nobelprismodtager Aage Bohr er død
Publicado: (2009)

Nobelpristageren Aage Bohr er død
Publicado: (2009)

17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
por: Sarangi, Upasana, et al.
Publicado: (2012)

Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia
por: Rosa, Lorena, et al.
Publicado: (2020)

Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor
por: García, Patricia, et al.
Publicado: (2020)

Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy
por: Rodrigues, Loreta M, et al.
Publicado: (2012)

Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
por: Vaseva, A V, et al.
Publicado: (2011)

Pauli letter collection: letter to Aage Bohr
por: Pauli, Wolfgang
Publicado: (2005)

Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors
por: Murillo-Solano, Claribel, et al.
Publicado: (2017)

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
por: Buchegger, Kurt, et al.
Publicado: (2016)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
por: Subbannayya, Tejaswini, et al.
Publicado: (2015)

Functional Analysis of Hsp70 Inhibitors
por: Schlecht, Rainer, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_usk8a2tucltrs4lvtrt3cff00t